JBIO FY 2021 Earnings — Jade Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

JBIOJade Biosciences, Inc.

$491M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$15,000

Operating Income

-$23M

Net Income

-$23M

EPS (Diluted)

$-32.96

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$28M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$175M

Total Liabilities

$3M

Stockholders' Equity

$172M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$15,000	-$1,000	-1400.0%
Operating Income	-$23M	-$9M	-159.0%
Net Income	-$23M	-$10M	-138.9%